Status: affected by circulating vaccine-derived poliovirus

Circulation of vaccine-derived poliovirus type 1 (cVDPV1) has been confirmed in Indonesia. 

The detection of cVDPV1 underscores the importance of maintaining high routine vaccination coverage everywhere to minimize the risk and consequences of any poliovirus circulation as well as the need to ensure quality surveillance for early detection of any polioviruses. These events also underscore the risk posed by any low-level transmission of the virus. A robust outbreak response is needed to rapidly stop circulation and ensure sufficient vaccination coverage in the affected areas to prevent similar outbreaks in the future. WHO will continue to evaluate the epidemiological situation and outbreak response measures being implemented. 

Polio this week in Indonesia

  • No circulating vaccine-derived poliovirus type 1 (cVDPV1) cases were reported this week.  One cVDPV1 case was reported in 2018 from Papua province with onset of paralysis on 28 November 2018.
  • This outbreak is not linked to the cVDPV1 in neighbouring Papua New Guinea.
  • Learn more about Indonesia polio outbreak response through weekly situational report

International Health Regulations 

Countries affected by poliovirus transmission are subject to International Health Regulations Temporary Recommendations that request them to declare a case of polio as a national public health emergency and consideration vaccination of all international travellers, as per temporary recommendations issued as of  May 2019. 

Travel advice 

WHO’s International Travel and Health recommends that all travellers to polio-affected areas be fully vaccinated against polio. Residents (and visitors for more than 4 weeks) from infected areas should receive an additional dose of OPV or inactivated polio vaccine (IPV) within 4 weeks to 12 months of travel.

More on this outbreak

Situation report on Indonesia cVDPV1 outbreak.

More on vaccine-derived polioviruses